Johnson & Johnson: all 3,718 studies

Page 18 of 38. Open to participants first (155), then studies with results posted, then the rest; newest registration first within each.

• A Study of JNJ-77474462 (Bermekimab) in Healthy Participants of Japanese Descent Following Administration of Single Ascending Subcutaneous DosesCompletedNCT04544826Phase 1
• A Study of JNJ-77474462 in Healthy ParticipantsCompletedNCT04544813Phase 1
• A Study to Assess the Reversal of the Anticoagulant Effects of Milvexian by 4-Factor Prothrombin Complex Concentrate (4F-PCC) (Part 1) and Recombinant Human Factor VIIa (rFVIIa) (Part 2) in Healthy ParticipantsCompletedNCT04543383Phase 1
• A Study of JNJ-75348780 in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)CompletedNCT04540796Phase 1
• A Study of Macitentan/Tadalafil Combination Administered a Fixed-dose Combination Formulation Compared to the Reference Free Combination of Macitentan and TadalafilCompletedNCT04540744Phase 1
• A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant TherapyCompletedNCT04513912Phase 3
• A Controlled Clinical Study of 2 Different Moisturizers for the Relief of Dry SkinCompletedNCT04510103Not applicable
• A Study of Ad26.COV2.S in Adults (COVID-19)CompletedNCT04509947Phase 1
• A Study of Macitentan, in Healthy Japanese Male ParticipantsCompletedNCT04500808Phase 1
• Study to Estimate How Common it is to Have Genetic Variants Associated With NAFLDCompletedNCT04494360
• A Study of JNJ-64281802 Against Dengue Serotype 1 Infection in a Dengue Human Challenge Model in Healthy Adult ParticipantsWithdrawnNCT04480736Phase 2
• A Study for the Identification of Biomarker Signatures for Diagnosis of Pulmonary Hypertension (PH) in Participants at Low or Intermediate Probability of PH Undergoing Cardiac Magnetic Resonance ImagingCompletedNCT04480723Early Phase 1
• Impella ECP Early Feasibility StudyActive, not recruitingNCT04477603Not applicable
• An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment AlternativesCompletedNCT04476446Phase 3
• A Study to Evaluate the Effect of Renal Impairment on JNJ-56136379 in Adult ParticipantsTerminatedNCT04474210Phase 1
• The Smart Pump StudyStatus unknownNCT04465201Not applicable
• A Study to Describe Routine Treatment Pathways in Participants With Major Depression and Active Suicidal Ideation With Intent in ItalyCompletedNCT04463108
• A Registry Study of Palmoplantar Pustulosis (PPP) Treatment Patterns, Disease Burden and Treatment Outcomes in JapanCompletedNCT04459507
• A Study of JNJ-66525433 in Healthy Participants and Participants With Ulcerative ColitisTerminatedNCT04457960Phase 1
• A Study to Assess the Effects of Acid-Reducing Agent(s) on JNJ-64417184 in Healthy ParticipantsCompletedNCT04453189Phase 1
• Individual Patient Investigational New Drug (IND) Expanded Access Program of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy for Participant With Multiple MyelomaNo longer availableNCT04452994
• A Study of Oral Seltorexant as an add-on Medication to an Antidepressant on On-road Driving Performance in Participants With Major Depressive DisorderCompletedNCT04451187Phase 1
• A Study of Mouth Rinses in Type 1 and Type 2 Diabetic ParticipantsCompletedNCT04449952Phase 4
• A Study of JNJ-70033093 in Healthy ParticipantsCompletedNCT04448964Phase 1
• A Study of Guselkumab in Naive or Bio-experienced Participants With Regional (Facial and Genital) PsoriasisCompletedNCT04439526
• A Study to Evaluate the Effect of Renal Impairment on JNJ-64417184 and Its Two Minor Metabolites JNJ-68294291 and JNJ-65201526 in Adult ParticipantsTerminatedNCT04426357Phase 1
• A Study to Assess the Effects of Itraconazole and Rifampin on Lazertinib in Healthy Adult ParticipantsCompletedNCT04410094Phase 1
• A Study of (14C)-JNJ-73841937 (Lazertinib) in Healthy Male ParticipantsCompletedNCT04410081Phase 1
• A Study of JNJ-70218902 in Participants With Advanced Stage Solid TumorsCompletedNCT04397276Phase 1
• A Study of Severe Uterine Bleeding Following Exposure to Direct Oral AnticoagulantsCompletedNCT04394234
• A Study Evaluating Drug Drug Interaction Between Milvexian and Atorvastatin in Healthy ParticipantsCompletedNCT04388501Phase 1
• A Study to Evaluate the Single Vaccination of an Adenovirus Serotype 26 Pre-Fusion F (Ad26.preF) Based Respiratory Syncytial Virus (RSV) Vaccine in Japanese Adults Aged 60 Years and OlderCompletedNCT04354480Phase 1
• A Study of JNJ-53718678 in Participants With Hepatic ImpairmentTerminatedNCT04332523Phase 1
• A Study of Steady-state Carbamazepine on the Single-dose of Erdafitinib Tablets in Healthy Adult ParticipantsCompletedNCT04330248Phase 1
• A Study of Smoking Cessation Patterns in Participants Undergoing Lung SurgeryCompletedNCT04313361
• A Study of Infliximab in the Treatment of Chinese Children With Crohn's DiseaseCompletedNCT04312659
• A Study to Evaluate the Different Doses of VAC52416 (ExPEC10V) in Japanese AdultsCompletedNCT04306302Phase 1
• A Study of Different Oral Thin Film (S)-Ketamine Formulations for Sublingual Administration in Healthy ParticipantsCompletedNCT04300621Phase 1
• Safety and Effectiveness of ENTERPRISE 2 Device in the Endovascular Treatment of Intracranial AneurysmsActive, not recruitingNCT04289480
• A Study of Sublingually Administered (S)-Ketamine Oral Solution in Healthy ParticipantsCompletedNCT04282746Phase 1
• A Study to Investigate if Early Atrial Fibrillation (AF) Diagnosis Reduces Risk of Events Like Stroke in the Real-WorldCompletedNCT04276441
• Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial HypertensionActive, not recruitingNCT04273945Phase 3
• A Study of Pharmacodynamic and Genetic Parameters of Abira-DES Study Participants (NCT02217566) - Participants With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Following Unresponsive Treatment With DiethylstilbestrolCompletedNCT04268628
• A Study of Selexipag in Healthy Male ParticipantCompletedNCT04266756Phase 1
• Pre-Approval Access for Administration of Daratumumab Subcutaneously (SC) in Participants Who Are Unable to Receive Intravenous (IV) DaratumumabApproved for marketingNCT04264884
• A Study of Cusatuzumab in Combination With Azacitidine Compared With Azacitidine Alone in Patients With Higher-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) and Who Are Not Candidates for Hematopoietic Stem Cell Transplantation (HSCT)WithdrawnNCT04264806Phase 2
• A Study of JNJ-64417184, Administered as an Oral Solution, in Healthy ParticipantsCompletedNCT04258189Phase 1
• RETHINK REFLUX RegistryActive, not recruitingNCT04253392
• A Study in Healthy Participants to Assess the Effect of Darunavir, Emtricitabine, and Tenofovir Alafenamide in the Presence of Cobicistat When Administered as a Fixed Dose Combination (Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide) Compared to the Co-administration of the Separate AgentsTerminatedNCT04236453Phase 1
• A Study of Macitentan and Tadalafil as a Fixed Dose Combination and the Free Combination in Healthy Adult ParticipantsCompletedNCT04235270Phase 1
• A Study to Evaluate the Impact of Care4Today® IBD, a Smart System to Facilitate the Management of Crohn's Disease by Patients and Health Care ProvidersTerminatedNCT04232228
• A Study of the Newly Formulated Tylenol Tablet (Acetaminophen) to the Tylenol 8 Hour (H) Extended Release (ER) Tablet (Acetaminophen) in Healthy ParticipantsCompletedNCT04230252Phase 1
• A Study to Evaluate the Effects of Loperamide (JNJ-289679) on Electrocardiogram Intervals in Healthy Adult ParticipantsCompletedNCT04225078Phase 1
• A Study of JNJ-70033093 (BMS-986177) in Healthy Adult ParticipantsCompletedNCT04223349Phase 1
• Pre-Approval Access to JNJ-53718678 for the Treatment of Respiratory Syncytial Virus (RSV) Infection in (a) Immunocompromised Adult and Pediatric ParticipantsNo longer availableNCT04221412
• A Study of Newly Formulated Tylenol Tablet (Acetaminophen) and Tylenol 8 Hour (H) Extended Release (ER) Tablet (Acetaminophen) in Healthy ParticipantsCompletedNCT04214691Phase 1
• A 2-part Study to Investigate the Effect of Macitentan in Healthy Male ParticipantsCompletedNCT04211272Phase 1
• A Study of JNJ-64264681 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic LeukemiaCompletedNCT04210219Phase 1
• A Study to Evaluate the Effect of Hepatic Impairment on JNJ-56136379CompletedNCT04208399Phase 1
• A Study to Evaluate the Effect of Hepatic Impairment on JNJ-73763989CompletedNCT04208386Phase 1
• A Study to Assess the Effects of Itraconazole and Etravirine on JNJ-64417184 in Healthy Adult ParticipantsCompletedNCT04208373Phase 1
• A Study of Darunavir in Combination With Cobicistat or Ritonavir, and Dabigatran Etexilate in Healthy ParticipantsCompletedNCT04208061Phase 1
• A Study of JNJ-70033093 and Digoxin in Healthy ParticipantsCompletedNCT04206488Phase 1
• Clinical Investigation of the Cheetah System For The Correction of Myopia With and Without AstigmatismCompletedNCT04200898Not applicable
• A Study for the Identification of Biomarker Signatures for Early Detection of Pulmonary Hypertension (PH)CompletedNCT04193046Early Phase 1
• A Study of Combination Caplet With Loperamide Hydrochloride and Simethicone, and Imodium Express Tablets-lyophilizate Coadministered With Espumisan Capsule in Healthy VolunteersCompletedNCT04186936Phase 1
• Assessment of Levels of Intracellular Cytokines and Markers in Cells Recovered From the Anterior Eye (Phase 4)CompletedNCT04186858
• A Study to Investigate the Effect of JNJ-67953964 on Gastric Mucosal Integrity in Healthy Male and Female ParticipantsCompletedNCT04185051Phase 1
• Transbronchial Biopsy Assisted by Robot Guidance in the Evaluation of Tumors of the LungCompletedNCT04182815
• A Real-World Evidence Study in China of the Catalys Precision Laser SystemCompletedNCT04171518
• A Comparative Study of TECNIS Symfony Plus IOL and a Trifocal IOLCompletedNCT04156737Not applicable
• A Study of Apalutamide in Participants With Severe Hepatic Impairment Compared With Participants With Normal Hepatic FunctionCompletedNCT04154774Phase 1
• A Study of Subcutaneously-administered Guselkumab Delivered by 3 Different Devices in Healthy ParticipantsCompletedNCT04147338Phase 1
• A Study to Evaluate Virologic Response in Participants Newly Diagnosed With HIV-1CompletedNCT04147325
• The Global cVAD StudyActive, not recruitingNCT04136392
• A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple MyelomaActive, not recruitingNCT04133636Phase 2
• A Study of Intranasal Budesonide Aqueous Spray for Treatment of Rhinitis During Periods of High Airborne PollutionCompletedNCT04132570Phase 4
• A Study on Suicidality, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or LisdexamfetamineCompletedNCT04132557
• A Study of Subcutaneous Delivery of JNJ-54767414 in Chinese Participants With Multiple MyelomaCompletedNCT04121260Phase 1
• A Study in Healthy Volunteers to Assess the Effect of Different Types of Food on a Single-dose of JNJ-64417184 Administered as TabletsCompletedNCT04121052Phase 1
• Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic AnemiaActive, not recruitingNCT04119050Phase 2/3
• A Study of Label Compliance for Attention Deficit/Hyperactivity Disorder (ADHD) Medications in JapanCompletedNCT04113551
• Ex-vivo Adhesion of Bacteria to Different Contact Lens MaterialsWithdrawnNCT04108286Not applicable
• A Study of Subcutaneous Daratumumab Regimens in Combination With Bispecific T Cell Redirection Antibodies for the Treatment of Participants With Multiple MyelomaActive, not recruitingNCT04108195Phase 1
• A Study to Assess Interaction Between JNJ-64417184 and JNJ-53718678 After Single and Multiple Dosing in Healthy ParticipantsCompletedNCT04090086Phase 1
• A Study of Bedaquiline 100 Milligram (mg) Tablets Administered as Different Test Formulations Compared to the Commercial Tablet Formulation (F001) in Healthy Adult ParticipantsCompletedNCT04087759Phase 1
• A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung CancerActive, not recruitingNCT04077463Phase 1
• A Study of Ustekinumab in Chinese Participants With Active Systemic Lupus ErythematosusWithdrawnNCT04060888Phase 3
• A Study of Real-life Current Standards of Care in Patients With Relapsed and/or Refractory Multiple Myeloma Who Received at Least 3 Prior Lines of Therapy Including Proteasome Inhibitor (PI), Immunomodulatory Drug (IMID), and Cluster of Differentiation 38 (CD38) Monoclonal Antibody TreatmentCompletedNCT04035226
• A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in JapanCompletedNCT04034095
• A Study of JNJ-64140284 Solid Dose Formulations in Healthy Male ParticipantsTerminatedNCT04033458Phase 1
• Study of Guselkumab and Ustekinumab Following a Single Intravenous or Subcutaneous Administration in Healthy Chinese ParticipantsCompletedNCT04030533Phase 1
• A Study of New Transdermal Contraceptive Patch at End of Shelf Life and Currently Marketed EVRA at the Beginning of Shelf Life in Healthy WomenCompletedNCT04017195Phase 1
• FENIX™ Continence Restoration System RegistryCompletedNCT04007250
• Study to Assess the Acceptability of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed-Dose Combination (FDC) Tablets in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Pediatric Participants, Using Matching Placebo TabletsCompletedNCT04006704Phase 1
• First-in-Human Study of JNJ-74699157 in Participants With Tumors Harboring the KRAS G12C MutationCompletedNCT04006301Phase 1
• A Study of JNJ-73763989 in Healthy Japanese Adult ParticipantsCompletedNCT04002752Phase 1
• A Study to Assess Stroke Risk Among Users of Typical Versus Atypical Antipsychotics Stratified by Broad Age GroupCompletedNCT04002700
• A Study of Guselkumab for the Treatment of Palmoplantar-non-Pustular PsoriasisCompletedNCT03998683Phase 3
• A Study of a Single Subcutaneous Dose of JNJ-26366821 in Healthy ParticipantsCompletedNCT03990519Phase 1

← Johnson & Johnson overview and focus areas